ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors ...

Major domestic pharma companies are witnessing pricing pressure in the generics segment in the US, their largest export market. Many of them are trying to address this by focusing more on high-value ...

Almost two-thirds of adults in Canada are overweight or living with obesity, according to the U.S. telehealth company The United States telehealth upstart said the move is expected to help accelerate ...

Cuban urges FDA fee waiver to boost US generics manufacturing Cost Plus Drugs plans to boost US production if fees are waived FDA charges $360,000 per generic drug approval application Trump promised ...

Hims & Hers Health Inc. HIMS-N, one of the largest U.S. telehealth providers, is entering the Canadian market with the acquisition of Montreal-based Livewell on Thursday and expects to ride the wave ...

MISSOURI, USA — Missouri Attorney General Catherine Hanaway is asking a federal court to roll back the U.S. Food and Drug Administration’s recent decision to approve a new generic brand of ...

PHOENIX — With flu cases rising overseas in countries like the United Kingdom and a new variant identified in Japan, experts warn that the United States could face an earlier flu season this year.

Three years ago, the FDA found so many violations at a Nephron Pharmaceuticals manufacturing facility that the U.S. regulator admitted in a warning letter the issues were so numerous they couldn’t all ...

Over the past six months, numerous pharmaceutical companies have announced plans to invest in new U.S. manufacturing facilities within the next decade. This so-called “onshoring,” motivated by the ...